VERICEL CORPORATION Repayments of Long-Term Debt
VERICEL CORPORATION (VCEL) reported Repayments of Long-Term Debt of $252.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2017-11-07
- VERICEL CORPORATION repayments of long-term debt for the quarter ending 2014-06-30 was $2.00K, a 80.00% decline year-over-year.
- VERICEL CORPORATION repayments of long-term debt for the quarter ending 2014-03-31 was $4.00K, a 63.64% decline year-over-year.
- VERICEL CORPORATION repayments of long-term debt for the quarter ending 2013-12-31 was $4.00K, a 55.56% decline year-over-year.
- VERICEL CORPORATION repayments of long-term debt for the quarter ending 2013-09-30 was $9.00K, a 10.00% decline year-over-year.
- VERICEL CORPORATION repayments of long-term debt for fiscal 2013 was $34.00K, a 15.00% decline from fiscal 2012.
- VERICEL CORPORATION repayments of long-term debt for fiscal 2012 was $40.00K, a 82.38% decline from fiscal 2011.
- VERICEL CORPORATION repayments of long-term debt for fiscal 2011 was $227.00K.
- VERICEL CORPORATION repayments of long-term debt for fiscal 2010 was $479.00K, a 7.64% increase from fiscal 2009.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 267 month | Repayments of Long-term Debt 270 month | Repayments of Long-term Debt 273 month | Repayments of Long-term Debt 276 month | Repayments of Long-term Debt 279 month | Repayments of Long-term Debt 282 month | Repayments of Long-term Debt 285 month | Repayments of Long-term Debt 288 month | Repayments of Long-term Debt 291 month | Repayments of Long-term Debt 294 month | Repayments of Long-term Debt 297 month | Repayments of Long-term Debt 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | $252.00K 10-Q · filed 2017-11-07 | |||||||||||||||
| 2016-09-30 | $28.00K 10-Q · filed 2017-11-07 | |||||||||||||||
| 2014-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $6.00K 10-Q · filed 2014-08-14 | $10.00K derived: sum of 3 quarters · filed 2014-08-14 | $19.00K derived: sum of 4 quarters · filed 2014-08-14 | ||||||||||||
| 2014-03-31 | $4.00K 10-Q · filed 2014-05-15 | $8.00K derived: sum of 2 quarters · filed 2014-05-15 | $17.00K derived: sum of 3 quarters · filed 2014-05-15 | $27.00K derived: sum of 4 quarters · filed 2014-08-14 | $2.88M 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $13.00K derived: sum of 2 quarters · filed 2014-03-13 | $23.00K derived: sum of 3 quarters · filed 2014-08-14 | $34.00K 10-K · filed 2014-03-13 | $2.87M 10-K · filed 2014-03-13 | |||||||||||
| 2013-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $19.00K derived: sum of 2 quarters · filed 2014-08-14 | $30.00K 10-Q · filed 2013-11-12 | $39.00K derived: sum of 4 quarters · filed 2014-08-14 | $2.87M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $21.00K 10-Q · filed 2014-08-14 | $30.00K derived: sum of 3 quarters · filed 2014-08-14 | $40.00K derived: sum of 4 quarters · filed 2014-08-14 | $2.86M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $11.00K 10-Q · filed 2014-05-15 | $20.00K derived: sum of 2 quarters · filed 2014-05-15 | $30.00K derived: sum of 3 quarters · filed 2014-05-15 | $40.00K derived: sum of 4 quarters · filed 2014-05-15 | $2.85M 10-Q · filed 2013-05-08 | |||||||||||
| 2012-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $19.00K derived: sum of 2 quarters · filed 2014-03-13 | $29.00K derived: sum of 3 quarters · filed 2014-03-13 | $40.00K 10-K · filed 2014-03-13 | $2.84M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $20.00K derived: sum of 2 quarters · filed 2013-11-12 | $31.00K 10-Q · filed 2013-11-12 | $76.00K derived: sum of 4 quarters · filed 2014-03-13 | $2.83M 10-Q · filed 2012-11-08 | |||||||||||
| 2012-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $21.00K 10-Q · filed 2013-08-07 | $66.00K derived: sum of 3 quarters · filed 2014-03-13 | $124.00K derived: sum of 4 quarters · filed 2014-03-13 | $2.82M 10-Q · filed 2012-08-07 | |||||||||||
| 2012-03-31 | $11.00K 10-Q · filed 2013-05-08 | $56.00K derived: sum of 2 quarters · filed 2014-03-13 | $114.00K derived: sum of 3 quarters · filed 2014-03-13 | $174.00K derived: sum of 4 quarters · filed 2014-03-13 | $2.81M 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $103.00K derived: sum of 2 quarters · filed 2014-03-13 | $163.00K derived: sum of 3 quarters · filed 2014-03-13 | $227.00K 10-K · filed 2014-03-13 | $2.80M 10-K · filed 2012-03-15 | |||||||||||
| 2011-09-30 | $58.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $118.00K derived: sum of 2 quarters · filed 2012-11-08 | $182.00K 10-Q · filed 2012-11-08 | $2.75M 10-Q · filed 2011-11-08 | ||||||||||||
| 2011-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $124.00K 10-Q · filed 2012-08-07 | $2.70M 10-Q · filed 2011-08-15 | |||||||||||||
| 2011-03-31 | $64.00K 10-Q · filed 2012-05-10 | |||||||||||||||
| 2010-12-31 | $119.00K 10-K · filed 2013-03-18 | |||||||||||||||
| 2010-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $298.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2010-06-30 | $243.00K 10-Q · filed 2011-08-15 | $479.00K 10-K · filed 2013-03-18 | ||||||||||||||
| 2009-06-30 | $445.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |